DK2102216T3 - Fluorineret derivat af quinolein-2(1H)-on, fremgangsmåde til fremstilling af samme samt anvendelse deraf som syntesemellemprodukt - Google Patents

Fluorineret derivat af quinolein-2(1H)-on, fremgangsmåde til fremstilling af samme samt anvendelse deraf som syntesemellemprodukt

Info

Publication number
DK2102216T3
DK2102216T3 DK07871822.8T DK07871822T DK2102216T3 DK 2102216 T3 DK2102216 T3 DK 2102216T3 DK 07871822 T DK07871822 T DK 07871822T DK 2102216 T3 DK2102216 T3 DK 2102216T3
Authority
DK
Denmark
Prior art keywords
quinolein
preparation
same
synthesis intermediate
fluorinated derivative
Prior art date
Application number
DK07871822.8T
Other languages
Danish (da)
English (en)
Inventor
Veronique Moragues
Didier Legroux
Jose Ruiz-Montes
Laurent Salle
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38318660&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2102216(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK2102216T3 publication Critical patent/DK2102216T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK07871822.8T 2006-12-12 2007-12-10 Fluorineret derivat af quinolein-2(1H)-on, fremgangsmåde til fremstilling af samme samt anvendelse deraf som syntesemellemprodukt DK2102216T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0610802A FR2909670B1 (fr) 2006-12-12 2006-12-12 Derive fluore de quinoleine-2(1h)-one,son procede de preparation et son utilisation comme intermediaire de synthese
PCT/FR2007/002027 WO2008087277A1 (fr) 2006-12-12 2007-12-10 Derive fluore de ouinoleine-2(1h)-one, son procede de preparation et son utilisation comme intermediaire de synthese

Publications (1)

Publication Number Publication Date
DK2102216T3 true DK2102216T3 (da) 2010-11-15

Family

ID=38318660

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07871822.8T DK2102216T3 (da) 2006-12-12 2007-12-10 Fluorineret derivat af quinolein-2(1H)-on, fremgangsmåde til fremstilling af samme samt anvendelse deraf som syntesemellemprodukt

Country Status (20)

Country Link
US (1) US7943769B2 (pt)
EP (1) EP2102216B1 (pt)
JP (1) JP2010512373A (pt)
AR (1) AR064210A1 (pt)
AT (1) ATE474841T1 (pt)
CL (1) CL2007003602A1 (pt)
CY (1) CY1110790T1 (pt)
DE (1) DE602007007988D1 (pt)
DK (1) DK2102216T3 (pt)
ES (1) ES2348822T3 (pt)
FR (1) FR2909670B1 (pt)
HR (1) HRP20100571T1 (pt)
PE (1) PE20081405A1 (pt)
PL (1) PL2102216T3 (pt)
PT (1) PT2102216E (pt)
RS (1) RS51439B (pt)
SI (1) SI2102216T1 (pt)
TW (1) TW200829592A (pt)
UY (1) UY30784A1 (pt)
WO (1) WO2008087277A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
CZ288149B6 (en) 1995-09-15 2001-05-16 Sanofi Synthelabo Derivatives of 2(1H)-quinolone, process of their preparation and pharmaceutical preparation in which they are comprised
FR2738823B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CL2007003602A1 (es) 2009-03-27
ES2348822T3 (es) 2010-12-15
EP2102216A1 (fr) 2009-09-23
HRP20100571T1 (hr) 2010-11-30
FR2909670A1 (fr) 2008-06-13
PL2102216T3 (pl) 2010-12-31
US7943769B2 (en) 2011-05-17
US20100094005A1 (en) 2010-04-15
CY1110790T1 (el) 2015-06-10
JP2010512373A (ja) 2010-04-22
SI2102216T1 (sl) 2010-11-30
AR064210A1 (es) 2009-03-18
RS51439B (en) 2011-04-30
PT2102216E (pt) 2010-10-04
ATE474841T1 (de) 2010-08-15
TW200829592A (en) 2008-07-16
PE20081405A1 (es) 2008-11-14
DE602007007988D1 (de) 2010-09-02
FR2909670B1 (fr) 2010-07-30
WO2008087277A1 (fr) 2008-07-24
EP2102216B1 (fr) 2010-07-21
UY30784A1 (es) 2008-07-31

Similar Documents

Publication Publication Date Title
DK1981863T3 (da) Fremgangsmåde til fremstilling af aminocrotonylaminosubtituerede quinazolinderivater
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
FR20C1027I2 (fr) Derives de tiglien-3-one
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
DK2084174T3 (da) Fremstilling af ribofuranosylpyrimidinnukleotider
DK2094676T3 (da) Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
DK1858342T3 (da) Fremgangsmåde til fremstilling af ernæringssammensætninger
DK1869065T3 (da) Fremgangsmåde til kromatografi med svag opdeling
DK2004654T3 (da) Pyrazolopyrimidin derivater til anvendelse som kinase antagonister
CR10823A (es) Formulacion parenteral de anticuerpos abeta
DK2049500T3 (da) Cyclopenta [d]-pyrimidiner som AKT-proteinkinase-inhibitorer
DK1917253T3 (da) Fremgangsmåde til fremstilling af betamimetika
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
DE602006003628D1 (de) Purinderivate als a2a-rezeptoragonisten
DK1813678T3 (da) Fremgangsmåde til fremstilling af glycogen
ATE545417T1 (de) Pyrazoloä3,4-büpyridin-derivate als phosphodiesterasehemmer
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
NO20091266L (no) Fremgangsmåter for administrering av langvarige hypoglykemiske midler
DK2118006T3 (da) Fremgangsmåde til fremstilling af silicapræparater, silicapræparater samt anvendelser deraf
DK2146944T3 (da) Fremgangsmåde til fremstillingen af 18f-mærkede folater
HK1122797A1 (en) Derivatives of pyrido